STOCK TITAN

ASGN Incorporated (ASGN) Financials

ASGN
Trailing 12 months to March 31, 2026
Revenue $4.0B -1.0% YoY
Net Income $98.1M -37.9% YoY
EPS (Diluted) $2.60 FY2025 annual
Free Cash Flow $290.6M -5.9% YoY
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed Apr 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ASGN SEC filings page.

ASGN Incorporated (ASGN) reported $4.0B in revenue over the twelve months to Mar 31, 2026, down 1.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ASGN FY2025

ASGN remains cash-generative, but falling operating margins and rising leverage show a business becoming less profitable on a smaller revenue base.

Revenue slipped from $4.01B in FY2021 to $3.98B in FY2025, indicating the recent weakness is not simply rapid growth pausing. By FY2025, operating margin was 5.8% and debt-to-equity was 0.6x, showing thinner operating economics alongside greater balance-sheet dependence.

Cash conversion remained better than accounting profitability: FY2025 operating cash flow was $328M versus net income of $114M, so earnings converted into more cash than reported profit alone suggests. After capital spending, free cash flow was $288M, down from $365M in FY2024, pointing to positive but weakening cash generation.

Share repurchases reduced diluted shares from 51.8M in FY2021 to 41.3M in FY2025, but this capital return occurred as debt-to-equity rose from 0.6x to 0.6x. Goodwill reached $2.1B against total assets of $3.7B, making acquisition-related assets a substantial part of the balance sheet.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 49 / 100
Financial Health Score 49/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of ASGN Incorporated's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
64

ASGN Incorporated has an operating margin of 5.8%, meaning the company retains $6 of operating profit per $100 of revenue. This results in a moderate score of 64/100, indicating healthy but not exceptional operating efficiency. This is down from 7.4% the prior year.

Growth
15

ASGN Incorporated's revenue declined 2.9% year-over-year, from $4.1B to $4.0B. This contraction results in a growth score of 15/100.

Leverage
22

ASGN Incorporated has elevated debt relative to equity (D/E of 0.65), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 22/100, reflecting increased financial risk.

Liquidity
63

ASGN Incorporated's current ratio of 2.16 indicates adequate short-term liquidity, earning a score of 63/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
59

ASGN Incorporated has a free cash flow margin of 7.2%, earning a moderate score of 59/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
68

ASGN Incorporated earns a strong 6.3% return on equity (ROE), meaning it generates $6 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 68/100. This is down from 9.9% the prior year.

Altman Z-Score Grey Zone
2.13

ASGN Incorporated scores 2.13, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
4/9

ASGN Incorporated passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
2.89x

For every $1 of reported earnings, ASGN Incorporated generates $2.89 in operating cash flow ($327.9M OCF vs $113.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate
3.40x

ASGN Incorporated earns $3.40 in operating income for every $1 of interest expense ($230.3M vs $67.7M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$968.3M
YoY0.0%
QoQ-1.2%
5Y CAGR+1.3%
10Y CAGR+5.2%

ASGN Incorporated generated $968.3M in revenue in Q1 2026. That is unchanged from the same quarter a year earlier. Against the prior quarter it is down 1.2%.

EBITDA
$55.7M
YoY-22.9%

ASGN Incorporated's EBITDA was $55.7M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 22.9% from the same quarter a year earlier.

Net Income
$5.5M
YoY-73.7%
QoQ-78.2%
5Y CAGR-35.4%
10Y CAGR-10.9%

ASGN Incorporated reported $5.5M in net income in Q1 2026. This represents a decrease of 73.7% from the same quarter a year earlier. Against the prior quarter it is down 78.2%.

EPS (Diluted)
$0.13
YoY-72.9%

ASGN Incorporated earned $0.13 per diluted share (EPS) in Q1 2026. This represents a decrease of 72.9% from the same quarter a year earlier.

Cash & Balance Sheet

Free Cash Flow
$9.1M
YoY+37.9%
QoQ-90.3%
5Y CAGR-39.3%
10Y CAGR-11.5%

ASGN Incorporated generated $9.1M in free cash flow in Q1 2026, representing cash available after capex. This represents an increase of 37.9% from the same quarter a year earlier. Against the prior quarter it is down 90.3%.

Cash & Debt
$143.6M
YoY+34.2%
QoQ-10.9%
5Y CAGR-18.0%
10Y CAGR+17.6%

ASGN Incorporated held $143.6M in cash against $1.5B in long-term debt as of Q1 2026.

Shares Outstanding
41M
YoY-6.4%
QoQ-0.7%
5Y CAGR-5.1%
10Y CAGR-2.6%

ASGN Incorporated had 41M shares outstanding in Q1 2026. This represents a decrease of 6.4% from the same quarter a year earlier. Against the prior quarter it is down 0.7%.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Gross Margin
27.5%
YoY-0.9pp
QoQ-1.4pp
5Y change+0.7pp
10Y change-4.7pp

ASGN Incorporated's gross margin was 27.5% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is down 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.4 percentage points.

Operating Margin
2.9%
YoY-1.9pp
QoQ-2.9pp

ASGN Incorporated's operating margin was 2.9% in Q1 2026, reflecting core business profitability. This is down 1.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.9 percentage points.

Net Margin
0.6%
YoY-1.6pp
QoQ-2.0pp
5Y change-4.8pp
10Y change-2.4pp

ASGN Incorporated's net profit margin was 0.6% in Q1 2026, showing the share of revenue converted to profit. This is down 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.0 percentage points.

Return on Equity
0.3%
YoY-0.9pp
QoQ-1.1pp
5Y change-2.7pp
10Y change-1.8pp

ASGN Incorporated's ROE was 0.3% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.1 percentage points.

Capital Allocation

Share Buybacks
$39.0M
YoY-22.6%
QoQ-39.3%

ASGN Incorporated spent $39.0M on share buybacks in Q1 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 22.6% from the same quarter a year earlier. Against the prior quarter it is down 39.3%.

Capital Expenditures
$9.4M
YoY-7.8%
QoQ+9.3%
5Y CAGR+0.2%
10Y CAGR+2.6%

ASGN Incorporated invested $9.4M in capex in Q1 2026, funding long-term assets and infrastructure. This represents a decrease of 7.8% from the same quarter a year earlier. Against the prior quarter it is up 9.3%.

R&D Spending

Not reported for Q1 2026.

ASGN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ASGN quarterly income statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Revenue$968.3M0.0%$980.1M-0.5%$1.0B-1.9%$1.0B-1.4%$968.3M-7.7%$985.0M-8.3%$1.0B-7.7%$1.0B-8.5%
Cost of Revenue$701.7M+1.3%$696.6M-0.3%$714.5M-2.2%$727.3M-0.9%$692.9M-8.0%$699.0M-9.1%$730.6M-8.0%$733.6M-8.8%
Gross Profit$266.6M-3.2%$283.5M-0.9%$296.9M-1.2%$293.3M-2.6%$275.4M-7.0%$286.0M-6.2%$300.4M-6.8%$301.1M-7.7%
SG&A Expenses$224.4M+4.6%$210.5M+6.4%$212.2M+2.3%$216.8M+5.4%$214.5M+2.0%$197.9M-2.8%$207.5M+0.7%$205.6M-2.3%
Operating Income$27.7M-40.6%$56.2M-24.3%$67.9M-13.9%$59.6M-25.9%$46.6M-34.3%$74.2M-11.0%$78.9M-20.0%$80.4M-17.9%
EBITDA$55.7M-22.9%N/AN/AN/A$72.2M-24.3%$98.1M-10.1%$102.3M-17.1%$104.9M-14.6%
Interest Expense$17.1M+11.0%$16.7M+12.1%$17.4M+8.8%$18.2M+15.2%$15.4M-12.5%$14.9M-10.8%$16.0M-13.5%$15.8M0.0%
Income Tax$5.1M-50.5%$14.3M-15.4%$12.4M-19.5%$12.1M-30.5%$10.3M-32.2%$16.9M+3.0%$15.4M-25.6%$17.4M-20.9%
Net Income$5.5M-73.7%$25.2M-40.6%$38.1M-19.8%$29.3M-37.9%$20.9M-45.1%$42.4M-15.7%$47.5M-20.0%$47.2M-21.5%
EPS (Basic)$0.13-72.9%N/A$0.88-17.8%$0.67-35.0%$0.48-41.5%N/A$1.07-13.0%$1.03-16.3%
EPS (Diluted)$0.13-72.9%N/A$0.87-17.9%$0.67-34.3%$0.48-40.7%N/A$1.06-13.8%$1.02-16.4%
Diluted Shares (Avg)41M-5.9%N/A44M-2.9%44M-4.6%44M-6.2%N/A45M-7.0%46M-6.3%

Not reported in any period shown, so not listed: R&D Expenses.

ASGN Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ASGN quarterly balance sheet
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Total Assets$4.0B+8.9%$3.7B+7.2%$3.7B+7.8%$3.7B+7.7%$3.7B+6.0%$3.4B-3.3%$3.4B-4.1%$3.5B-3.1%
Current Assets$970.3M+10.3%$916.2M-0.2%$918.4M+1.2%$916.3M+0.3%$879.6M-5.8%$917.7M-5.7%$907.3M-8.7%$913.9M-6.0%
Cash & Equivalents$143.6M+34.2%$161.2M-21.4%$126.5M-24.1%$138.9M+5.1%$107.0M-32.4%$205.2M+16.7%$166.6M+14.4%$132.2M+40.9%
Accounts Receivable$744.4M+5.5%$674.4M+3.6%$710.4M+3.5%$691.3M-4.2%$705.3M-2.8%$650.8M-12.2%$686.4M-14.7%$721.4M-13.0%
Goodwill$2.3B+6.6%$2.1B+13.2%$2.1B+13.1%$2.1B+13.1%$2.1B+13.0%$1.9B-0.1%$1.9B0.0%$1.9B0.0%
Total Liabilities$2.2B+17.5%$1.9B+13.4%$1.9B+12.7%$1.9B+14.9%$1.9B+17.1%$1.7B0.0%$1.7B-0.8%$1.6B+0.5%
Current Liabilities$461.9M+24.3%$424.3M+15.6%$462.3M+14.5%$434.6M+11.4%$371.5M-0.1%$367.1M-6.9%$403.6M-8.9%$390.1M-6.4%
Non-Current Liabilities$1.8B+15.9%$1.4B+12.7%$1.4B+12.1%$1.5B+16.0%$1.5B+22.1%$1.3B+2.1%$1.3B+2.2%$1.3B+2.8%
Long-Term Debt$1.5B+14.0%$1.2B+13.1%$1.2B+12.7%$1.2B+17.0%$1.3B+23.8%$1.0B-0.3%$1.0B-0.3%$1.0B0.0%
Total Equity$1.8B-0.2%$1.8B+1.5%$1.8B+3.3%$1.8B+1.0%$1.8B-3.7%$1.8B-6.1%$1.8B-7.0%$1.8B-6.2%
Retained Earnings$1.1B-0.5%$1.1B-0.5%$1.1B+1.4%$1.1B-1.9%$1.1B-7.5%$1.1B-8.2%$1.1B-9.6%$1.1B-8.3%

Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments.

ASGN Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ASGN quarterly cash flow statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Operating Cash Flow$18.5M+10.1%$102.3M+2.1%$83.9M-38.2%$124.9M+37.7%$16.8M-77.1%$100.2M-13.9%$135.8M-7.9%$90.7M-19.4%
Depreciation & Amortization$28.0M+9.4%N/AN/AN/A$25.6M+4.5%$23.9M-7.0%$23.4M-5.6%$24.5M-1.6%
Stock-Based Compensation$15.1M+9.4%N/AN/AN/A$13.8M+17.9%N/AN/AN/A
Capital Expenditures$9.4M-7.8%$8.6M-23.9%$11.9M+50.6%$9.1M+71.7%$10.2M-5.6%$11.3M+56.9%$7.9M-19.4%$5.3M-52.7%
Free Cash Flow$9.1M+37.9%$93.7M+5.4%$72.0M-43.7%$115.8M+35.6%$6.6M-89.4%$88.9M-18.6%$127.9M-7.1%$85.4M-15.7%
Investing Cash Flow-$293.0M+7.4%-$6.6M+41.6%-$11.9M-48.8%-$9.1M-75.0%-$316.3M-2828.7%-$11.3M-56.9%-$8.0M+18.4%-$5.2M+53.6%
Financing Cash Flow$257.6M+28.0%-$61.2M-23.4%-$84.5M+9.0%-$84.9M+23.3%$201.2M+351.5%-$49.6M+37.5%-$92.9M-8.5%-$110.7M-52.5%
Share Buybacks$39.0M-22.6%$64.2M+46.2%$46.0M-51.9%$9.5M-91.2%$50.4M-36.8%$43.9M-41.8%$95.6M+4.7%$108.0M+87.5%

Not reported in any period shown, so not listed: Dividends Paid.

ASGN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ASGN quarterly financial ratios
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Gross Margin27.5%-0.9pp28.9%-0.1pp29.4%+0.2pp28.7%-0.4pp28.4%+0.2pp29.0%+0.7pp29.1%+0.3pp29.1%+0.3pp
Operating Margin2.9%-1.9pp5.7%-1.8pp6.7%-0.9pp5.8%-1.9pp4.8%-1.9pp7.5%-0.2pp7.6%-1.2pp7.8%-0.9pp
Net Margin0.6%-1.6pp2.6%-1.7pp3.8%-0.8pp2.9%-1.7pp2.2%-1.5pp4.3%-0.4pp4.6%-0.7pp4.6%-0.8pp
Return on Equity0.3%-0.9pp1.4%-1.0pp2.1%-0.6pp1.6%-1.0pp1.2%-0.9pp2.4%-0.3pp2.7%-0.4pp2.6%-0.5pp
Return on Assets0.1%-0.4pp0.7%-0.5pp1.0%-0.3pp0.8%-0.6pp0.6%-0.5pp1.2%-0.2pp1.4%-0.3pp1.4%-0.3pp
Current Ratio2.10-0.3x2.16-0.3x1.99-0.3x2.11-0.2x2.37-0.1x2.500.0x2.250.0x2.340.0x
Debt-to-Equity0.82+0.1x0.65+0.1x0.64+0.1x0.66+0.1x0.72+0.2x0.580.0x0.580.0x0.570.0x
Asset Turnover0.240.0x0.270.0x0.270.0x0.270.0x0.260.0x0.290.0x0.300.0x0.300.0x
FCF Margin0.9%+0.3pp9.6%+0.5pp7.1%-5.3pp11.3%+3.1pp0.7%-5.3pp9.0%-1.1pp12.4%+0.1pp8.3%-0.7pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
ASGN Incorporated ASGN FY2025 $4.0B $113.5M 2.9% $833.7M 49/100
DXC Technology Company DXC FY2026 $12.6B $18.0M 0.1% $1.8B 54/100
GLOBANT S.A. GLOB FY2025 $2.5B $104.0M 4.2% $1.5B 44/100
VNET Group, Inc. VNET FY2025 N/A -$36.0M N/A $1.5B —
Formula Systems 1985 Ltd FORTY FY2025 $2.6B $669.1M 25.5% $1.7B 34/100
WNS (Holdings) Limited WNS FY2025 $1.3B $170.1M 12.9% $3.3B 67/100

Frequently Asked Questions

What is ASGN Incorporated's annual revenue?

ASGN Incorporated (ASGN) reported $4.0B in total revenue for fiscal year 2025. This represents a -2.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is ASGN Incorporated's revenue growing?

ASGN Incorporated (ASGN) revenue declined by 2.9% year-over-year, from $4.1B to $4.0B in fiscal year 2025.

Is ASGN Incorporated profitable?

Yes, ASGN Incorporated (ASGN) reported a net income of $113.5M in fiscal year 2025, with a net profit margin of 2.9%.

ASGN Incorporated (ASGN) reported diluted earnings per share of $2.60 for fiscal year 2025. This represents a -32.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

ASGN Incorporated (ASGN) had EBITDA of $343.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, ASGN Incorporated (ASGN) had $161.2M in cash and equivalents against $1.2B in long-term debt.

ASGN Incorporated (ASGN) had a gross margin of 28.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

ASGN Incorporated (ASGN) had an operating margin of 5.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

ASGN Incorporated (ASGN) had a net profit margin of 2.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

ASGN Incorporated (ASGN) has a return on equity of 6.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

ASGN Incorporated (ASGN) generated $288.1M in free cash flow during fiscal year 2025. This represents a -21.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

ASGN Incorporated (ASGN) generated $327.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

ASGN Incorporated (ASGN) had $3.7B in total assets as of fiscal year 2025, including both current and long-term assets.

ASGN Incorporated (ASGN) invested $39.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, ASGN Incorporated (ASGN) spent $170.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

ASGN Incorporated (ASGN) had 41M shares outstanding as of fiscal year 2025.

ASGN Incorporated (ASGN) had a current ratio of 2.16 as of fiscal year 2025, which is generally considered healthy.

ASGN Incorporated (ASGN) had a debt-to-equity ratio of 0.65 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

ASGN Incorporated (ASGN) had a return on assets of 3.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

ASGN Incorporated (ASGN) has an Altman Z-Score of 2.13, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

ASGN Incorporated (ASGN) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

ASGN Incorporated (ASGN) has an earnings quality ratio of 2.89x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

ASGN Incorporated (ASGN) has an interest coverage ratio of 3.40x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

ASGN Incorporated (ASGN) scores 49 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top